Recently, it was observed that luteolin alleviates the inflammatory responses and secretions of inflammatory factors in human bronchial epithelial cells during asthma by inhibiting IL‐1β and MAPK signaling and reduced the secretion of IL‐36γ (Qiao et al. 2023). Here, IL36G is linked to asthma.